GGrantIndex
Sort

27,075 grants matching cholesterol

Cholesterol Regulation of Endothelial K+ Channels

$694,203
Irena Levitan · University Of Illinois At Chicago · R01 · FY2021 · HL

A hypercholesterolemia-induced immunometabolite in atherosclerosis

$694,138
Prediman Krishan Shah · Cedars-Sinai Medical Center · R01 · FY2022 · HL

Putting CDSMP to Work: Implementation of the Live Healthy, Work Healthy Program

$694,067
Mark G. Wilson · University Of Georgia · R01 · FY2016 · HL

Managing Atherosclerosis by Modulating HDL Function

$693,767
M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2019 · HL

Managing Atherosclerosis by Modulating HDL Function

$693,767
M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2020 · HL

Managing Atherosclerosis by Modulating HDL Function

$693,767
M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2021 · HL

Native Alzheimer Disease Resource Center for Minority Aging Research (NAD-RCMAR)

$693,698
James E Galvin · University Of Miami School Of Medicine · P30 · FY2023 · AG

Testing a Community Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease

$693,561
Russell V Luepker · University Of Minnesota · R01 · FY2016 · HL

Genetics of Human Hypertension

$693,509
Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2007 · HL

Lipid raft therapy – a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities

$693,497
Michael Ilya Bukrinsky · George Washington University · R01 · FY2021 · HL

Real-world translation of a dynamic and personalized intervention for shift workers

$693,433
Olivia Walch · Arcascope, Inc · R42 · FY2024 · HL

Proteomic discovery in an inception cohort of acute myocardial infarction survivors

$693,268
James S Floyd · University Of Washington · R01 · FY2023 · HL

Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery

$693,256
James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State

$693,205
Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2024 · HL

Clinic-based Intervention to Improve Medication Adherence to Reduce CVD Risks

$693,180
James G Christian · Phcc, Lp · R44 · FY2008 · HL

Targeting host lipid metabolism to limit tissue damage in necrotizing fasciitis

$693,175
Steven J Bensinger · University Of California Los Angeles · R01 · FY2025 · AI

Dopamine Receptor Proteomics

$693,174
David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS

Project 2: Response to Treatment

$693,087
David R Sherman · Seattle Children'S Hospital · U19 · FY2020 · AI

A simple dietary message to improve dietary quality for metabolic syndrome

$693,050
Yunsheng Ma · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · HL

Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic

$692,975
Lakshmidevi None Pulakat · Tufts Medical Center · R01 · FY2020 · HL

APEX: ADIPOSITY PREVENTION BY EXERCISE IN BLACK GIRLS

$692,942
Medical College Of Georgia (Mcg) · R01 · FY2001 · HL

Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway

$692,812
Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · HL

Colorado Center of Childhood Liver Disease Research Network

$692,742
Ronald J Sokol · University Of Colorado Denver · U01 · FY2017 · DK

Role of a Novel Hormone Complex, Fabkin, in Dyslipidemia and Inflammation in Atherosclerosis

$692,742
Gokhan S Hotamisligil · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · HL

MODELING DNA DIVERSITY IN CARDIOVASCULAR HEALTH/DISEASE

$692,664
University Of Washington · R01 · FY2001 · HL